Point-One Innovation Fund
VC Fund
Eindhoven, The Netherlands
Point-One Innovation Fund is a venture capital corporation that focuses on early stage technology startups in the Netherlands. It mainly focuses on nanotechnology and embedded systems, including semiconductors, embedded software, mechatronics, and photonics.Point-One Innovation Fund offers its customers with capital and consulting services tobuild consumer electronics, multimedia, communication, automotive, gaming, navigation, and medical devices; and mobile applications.Point-One Innovation Fund was founded by C J Koomen in Eindhoven, the Netherlands.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Point-One Innovation Fund invests in
Stages Point-One Innovation Fund invests in
Countries Point-One Innovation Fund invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
CJ Koomen
|
|||
Investment Focus
Industry
- Video 1 (20%)
- Medical 1 (20%)
- Software 1 (20%)
- Analytics 1 (20%)
- Real Time 1 (20%)
Stage
- Series B 2 (40%)
- Seed 1 (20%)
- Series A 1 (20%)
- Series C 1 (20%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
CJ Koomen
Founder
|
Founder | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Vector Fabrics
|
Vector Fabrics licenses programming tools to unlock the performance potential of the multicore platforms. The world is going multicore with two, four, and up to hundreds of processors on a chip. Performance and power consumption are critical to the success of software vendors in mobile, automotive, networking and industrial markets. Yet software isnot written to take advantage of more than one single core. Often, the anticipated speedup of parallel execution is not reached. The code modifications actually slow down the program. In addition, manual optimization leads to field recalls due to data races and related multicore programming errors. Vector Fabrics technology thoroughly analyzes the dynamic behavior of the software. Their products detect critical bugs in the dynamic behavior such as data races and potential deadlocks. The predictive profiling technology gives the programmer the insight how to change the software to fully use the parallel hardware. | Series C / Feb 01, 2015 | |
Hemics
|
Hemics is a medical device company active in the field of Rheumatoid Arthritis (RA). We aim at improving the quality of life of patients with RA by creating imaging devices that support the rheumatologist in monitoring and treatment of this disease.Its devices are based on the patented Optical Inflammation Detection technology, a non-invasive,fast and objective method that supports rheumatologists in the quantification of inflammation, a key parameter in the treatment of patients with RA.Hemics was founded as a spin-out of Royal Philips Electronics, where the Optical Inflammation Detection technology was invented. | Series B / Jan 09, 2015 | |
|
Vector Fabrics
|
Vector Fabrics licenses programming tools to unlock the performance potential of the multicore platforms. The world is going multicore with two, four, and up to hundreds of processors on a chip. Performance and power consumption are critical to the success of software vendors in mobile, automotive, networking and industrial markets. Yet software isnot written to take advantage of more than one single core. Often, the anticipated speedup of parallel execution is not reached. The code modifications actually slow down the program. In addition, manual optimization leads to field recalls due to data races and related multicore programming errors. Vector Fabrics technology thoroughly analyzes the dynamic behavior of the software. Their products detect critical bugs in the dynamic behavior such as data races and potential deadlocks. The predictive profiling technology gives the programmer the insight how to change the software to fully use the parallel hardware. | Series B / Oct 29, 2011 | |
|
Hemics
|
Hemics is a medical device company active in the field of Rheumatoid Arthritis (RA). We aim at improving the quality of life of patients with RA by creating imaging devices that support the rheumatologist in monitoring and treatment of this disease.Its devices are based on the patented Optical Inflammation Detection technology, a non-invasive,fast and objective method that supports rheumatologists in the quantification of inflammation, a key parameter in the treatment of patients with RA.Hemics was founded as a spin-out of Royal Philips Electronics, where the Optical Inflammation Detection technology was invented. | Series A / Sep 20, 2011 | |
Etulipa
|
Billboards that read like paper, but offer all the advantages of digital: real-time, targeted, still and video, on-the-spot advertising. | Seed / Dec 01, 2007 |
Co-Investors
BOM
3 deals together
Newion
2 deals together
Thuja Capital
2 deals together
DFZ Participaties
1 deal together
PPM Oost NV
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Point-One Innovation Fund invest in?
Point-One Innovation Fund invests primarily in Video, Medical and Software startups, most often at Series B and Seed stage. Most of the 5 investments tracked by Shizune back companies in The Netherlands. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Point-One Innovation Fund?
Public channels for Point-One Innovation Fund include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Point-One Innovation Fund?
The team at Point-One Innovation Fund includes CJ Koomen (Founder). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
